{"retracted":false,"update":{"timestamp":1452470400000,"doi":"10.1186/s12885-015-2046-7","type":"correction"},"doi":"10.1186/s12885-015-1936-z","journal":"BMC Cancer","publisher":"Springer Nature","title":"Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models"}
